Rapid-Cycling Bipolar Disorder

Kupka RW, Luckenbaugh MA, Post RM, et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry. 2003;64:1483-1494. Abstract
Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 1974;30:229-233. Abstract
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the systematic treatment enhancement program. Am J Psychiatry. 2004;161:1902-1908. Abstract
Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Arch Gen Psychiatry. 1992;49:126-131. Abstract
Koukopoulos A, Sani G, Koukopoulos AE, et al. Duration and stability of the rapid-cycling course: A long-term personal follow-up of 109 patients. J Affec Dis. 2003;73:75-85.
Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421-433. Abstract
Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988;145:179-184. Abstract
Wolpert EA, Goldberg JF, Harrow M. Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry. 1990;147:725-728. Abstract
Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 suppl):1-50.
Calabrese JR, Shelton MD. Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry. 2001;62(suppl 14):34-41. Abstract
Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand. 2003;108:4-14. Abstract
Shelton MD III, Rapport DJ, Youngstrom EA, et al. Is rapid cycling a predictor of nonresponse to lithium? Program and abstracts of the 157th Annual Meeting of the American Psychiatric Association; New York, NY; May 1-6, 2004. Abstract 759.
Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000;61:841-850. Abstract
Sanger TM, Tohen M, Vieta E, et al. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord. 2003;73:155-161. Abstract
Keck P, Corya S, Andersen SW, et al. Analysis of olanzapine/fluoxetine combination in the treatment of rapid-cycling bipolar depression (presentation). Program and abstracts of the 43rd Annual New Clinical Drug Evaluation Unit Meeting; Boca Raton, Florida; May 2003. Abstract I-100.
Vieta E. Calabrese J, McFadden W, et al. Quetiapine for the treatment of rapid-cycling bipolar depression. Program and abstracts of the European Stanley Foundation Conference on Bipolar Disorder; Aarhus, Denmark; September 24-26, 2004.
Suppes T, Ozcan ME, Carmody T. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord. 2004;6:329-332. Abstract
Grunze H, Amann B, Dittman S, et al. Clinical relevance and treatment possibilities of bipolar rapid cycling. Neuropsychobiology. 2002;45:20-26. Abstract
Pazzaglia PJ, Post RM, Ketter TA, et al. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatr Res. 1993;49:257-272.
Keck PE Jr., McElroy SL, Freeman MP, et al. Randomized, placebo-controlled trial of eicosopentanoic acid (EPA) in rapid cycling bipolar disorder. Program and abstracts of the 5th International Conference on Bipolar Disorder; Pittsburgh, Pennsylvania; June 12-14, 2003.
Satterfield JM. Adjunctive cognitive-behavioral therapy for rapid-cycling bipolar disorder: an empirical case study. Psychiatry. 1999;62:357-369. Abstract

processing....

Conclusion

Although it has been 30 years since the term rapid cycling was coined, the condition is still something of a mystery. It remains an open question as to whether rapid cycling is a transient or enduring phenomenon, and whether certain pharmacotherapies demonstrate compelling advantages over others. Rapid cycling may represent a negative prognostic factor more than a marker for specific treatment outcomes. Compounds that do not destabilize mood, particularly those with at least a moderate or large effect size for the treatment of depressive symptoms, may represent the most compelling and evidence-based interventions for this condition.

Supported by an independent educational grant from AstraZeneca.

« Back

Page 6 of 6

References

Rapid-Cycling Bipolar Disorder: Emerging Treatments and Enduring Controversies: Conclusion

Conclusion

Table of Contents

References

Faculty and Disclosures

Rapid-Cycling Bipolar Disorder: Emerging Treatments and Enduring Controversies: Conclusion

Conclusion

Table of Contents